At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AEMD Aethlon Medical
Trading 03-20 13:04:12 EDT
2.13
-0.08
-3.62%
High2.22Low2.13Vol8.67K
Open2.22D1 Closing2.21Amplitude4.07%
Mkt Cap2.80MTradable Cap2.79MTotal Shares1.32M
T/O19.01KT/O Rate0.66%Tradable Shares1.31M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Aethlon Medical Completes Pre-Funded Warrant Exercises, Simplifying Equity
TIPRANKS  ·  03-17
Aethlon Medical Completes Pre-Funded Warrant Exercises, Simplifying Equity
Aethlon Medical says all pre-funded warrants have been exercised
Reuters  ·  03-17
Aethlon Medical says all pre-funded warrants have been exercised
Aethlon Medical Engages Maxim Group to Review Strategic Alternatives, Including Potential Partnerships, Mergers and Acquisitions
Reuters  ·  03-12
Aethlon Medical Engages Maxim Group to Review Strategic Alternatives, Including Potential Partnerships, Mergers and Acquisitions
Aethlon Medical Engages Maxim Group Llc to Evaluate Strategic Opportunities
THOMSON REUTERS  ·  03-12
Aethlon Medical Engages Maxim Group Llc to Evaluate Strategic Opportunities
**Aethlon Medical CEO Jim Frakes to present at Life Sciences Investor Forum**
Reuters  ·  03-06
**Aethlon Medical CEO Jim Frakes to present at Life Sciences Investor Forum**
Aethlon Medical to Present at Emerging Growth Conference
Reuters  ·  02-23
Aethlon Medical to Present at Emerging Growth Conference
Aethlon Medical Posts Q3 Results, Highlights Hemopurifier Progress
TIPRANKS  ·  02-13
Aethlon Medical Posts Q3 Results, Highlights Hemopurifier Progress
Aethlon Medical Q3 operating expenses up 13.6% yr/yr
Reuters  ·  02-13
Aethlon Medical Q3 operating expenses up 13.6% yr/yr
AEMD Q3 operating expenses rise 13.6% to USD 2.06 million
Reuters  ·  02-13
AEMD Q3 operating expenses rise 13.6% to USD 2.06 million
Aethlon Medical Q3 EPS $(2.45) Beats $(2.57) Estimate
Benzinga  ·  02-13
Aethlon Medical Q3 EPS $(2.45) Beats $(2.57) Estimate
Press Release: Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
Dow Jones  ·  02-13
Press Release: Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
Aethlon Medical Inc. veröffentlicht demnächst neue Quartalszahlen und lädt zur Investorenkonferenz ein
Reuters  ·  02-04
Aethlon Medical Inc. veröffentlicht demnächst neue Quartalszahlen und lädt zur Investorenkonferenz ein
Aethlon Medical Amends Warrants to Allow Immediate Exercise
TIPRANKS  ·  01-27
Aethlon Medical Amends Warrants to Allow Immediate Exercise
Aethlon Medical Inc. Announces Date for Upcoming Annual Stockholder Meeting
Reuters  ·  01-17
Aethlon Medical Inc. Announces Date for Upcoming Annual Stockholder Meeting
BRIEF-Aethlon Medical Inc Files For Common Stock Offering Of $15 Million, SEC Filing Shows
Reuters  ·  2025-12-24
BRIEF-Aethlon Medical Inc Files For Common Stock Offering Of $15 Million, SEC Filing Shows
Aethlon Medical Inc: Files for Common Stock Offering of $15 Mln - SEC Filing
THOMSON REUTERS  ·  2025-12-24
Aethlon Medical Inc: Files for Common Stock Offering of $15 Mln - SEC Filing
BRIEF-Aethlon Medical Announces Pricing Of A Private Placement And Warrant Inducement
Reuters  ·  2025-12-05
BRIEF-Aethlon Medical Announces Pricing Of A Private Placement And Warrant Inducement
Press Release: Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
Dow Jones  ·  2025-12-05
Press Release: Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
Aethlon Medical Reports Hemopurifier Removes Inflammatory Extracellular Vesicles in Long COVID Study
Reuters  ·  2025-12-02
Aethlon Medical Reports Hemopurifier Removes Inflammatory Extracellular Vesicles in Long COVID Study
Maxim Group Reaffirms Their Hold Rating on Aethlon Medical (AEMD)
TIPRANKS  ·  2025-11-14
Maxim Group Reaffirms Their Hold Rating on Aethlon Medical (AEMD)

Introduction

Company Name.
Aethlon Medical
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Issue price:
--